Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitapride-M 50/1000 Tablet PR

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitapride-M 50/1000 Tablet PR

Diabex Duo 50/1000 tablets are a dual-action medication managing elevated blood glucose in individuals with type 2 diabetes. This helps mitigate serious diabetic complications like nephropathy and visual impairment, potentially lowering cardiovascular event risk. Diabex Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming it with meals minimizes gastrointestinal distress. Consistent, daily dosing at the same time maximizes efficacy; discontinue only under physician guidance. Continued adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control; lifestyle significantly impacts glucose management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; learn to identify and treat this complication. This medication isn't universally suitable. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Uses of Sitapride-M 50/1000 Tablet PR

Managing type 2 diabetes

Major Benefits of Sitapride-M 50/1000 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Sitapride-M 50/1000 Tablet PR with meals.

Common Side effects of Sitapride-M 50/1000 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapride-M 50/1000 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Ingest Sitapride-M 50/1000 Tablet PR with a meal.

How Sitapride-M 50/1000 Tablet PR works:

Sitagliptin and metformin, combined as Sitapride-M 50/1000 Tablet PR, offer enhanced blood glucose management. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, acts by reducing liver glucose generation, slowing intestinal glucose absorption, and increasing insulin responsiveness. This dual mechanism provides superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitapride-M 50/1000 Tablet PR with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitapride-M 50/1000 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitapride-M 50/1000 tablets while breastfeeding is likely inadvisable due to safety concerns. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitapride-M 50/1000 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Use of Sitapride-M 50/1000 Tablet PR is likely contraindicated for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Sitapride-M 50/1000 Tablet PR :

Should you forget a scheduled dose of Sitapride-M 50/1000 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitapride-M 50/1000 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitapride-M 50/1000 Tablet PR

Sitapride-M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitapride-M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To prevent these complications, annual supplemental vitamin B12 is recommended by some researchers.
Sitapride-M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitapride-M 50/1000 Tablet PR components or excipients should not use this medication. Similarly, its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapride-M 50/1000 Tablet PR with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 50/1000 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitapride-M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitapride-M 50/1000 Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitapride-M 50/1000 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapride-M 50/1000 Tablet PR with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin + Metformin (Sitapride-M 50/1000 Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitapride-M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitapride-M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitapride-M 50/1000 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapride-M 50/1000 Tablet PR with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitapride-M 50/1000 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as MALA (Metformin-associated lactic acidosis), this rare side effect is linked to metformin use and necessitates avoidance in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitapride-M 50/1000 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitapride-M 50/1000 Table...
141
MRP 164
14% off